Stock ScreenerStock IdeasZen Ratings + Top Analysts
Stocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: May 4, 2026
The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.

Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
LLY
ELI LILLY & CO
NYSE
Drug Manufacturers - General
A$907.21B$963.333.07%$33.17B34.17x2.74
United States
62
GILD
GILEAD SCIENCES INC
NASDAQ
Drug Manufacturers - General
A$163.43B$131.650.62%$13.58B19.25x1.60
United States
55
CAH
CARDINAL HEALTH INC
NYSE
Medical Distribution
A$45.73B$195.241.22%$3.28B29.72x-20.96
United States
35
DXCM
DEXCOM INC
NASDAQ
Medical Devices
A$23.67B$61.353.02%$1.48B25.56x1.24
United States
51
THC
TENET HEALTHCARE CORP
NYSE
Medical Care Facilities
A$15.79B$183.273.47%$3.93B9.46x4.64
United States
40
JLL
JONES LANG LASALLE INC
NYSE
Real Estate Services
A$14.63B$315.24-0.91%$1.45B16.62x1.43
United States
39
LEVI
LEVI STRAUSS & CO
NYSE
Apparel Manufacturing
A$8.57B$22.280.00%$1.03B14.19x1.98
United States
48
BCO
BRINKS CO
NYSE
Security & Protection Services
A$4.42B$107.520.72%$879.30M22.73x24.96
United States
43
AMRX
AMNEAL PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$4.04B$12.83-0.31%$548.00M55.78x-52.97
30
KTB
KONTOOR BRANDS INC
NYSE
Apparel Manufacturing
A$3.99B$72.20-1.58%$408.62M17.61x3.57
United States
47
LIVN
LIVANOVA PLC
NASDAQ
Medical Devices
A$3.34B$61.001.50%-$111.91M-13.71x1.17
United Kingdom
20
DBD
DIEBOLD NIXDORF INC
NYSE
Software - Application
A$2.70B$77.861.37%$352.40M26.30x2.74
United States
39
VCYT
VERACYTE INC
NASDAQ
Biotechnology
A$2.63B$33.090.52%$92.61M39.39x0.07
United States
59
ATRO
ASTRONICS CORP
NASDAQ
Aerospace & Defense
A$2.54B$71.21-0.27%$72.51M85.80x4.05
United States
36
HLIO
HELIOS TECHNOLOGIES INC
NYSE
Specialty Industrial Machinery
A$2.21B$66.84-2.28%$147.30M45.78x0.63
United States
33
HCI
HCI GROUP INC
NYSE
Insurance - Property & Casualty
A$1.98B$152.30-0.83%$428.31M6.20x1.36
United States
59
INVA
INNOVIVA INC
NASDAQ
Biotechnology
A$1.71B$23.110.52%$383.79M5.75x0.39
United States
56
DFIN
DONNELLEY FINANCIAL SOLUTIONS INC
NYSE
Capital Markets
A$1.30B$50.800.99%$122.10M43.05x1.11
United States
37
PHAR
PHARMING GROUP NV
NASDAQ
Biotechnology
A$1.19B$16.982.72%$28.35M361.28x0.80
Netherlands
30
INR
INFINITY NATURAL RESOURCES INC
NYSE
Oil & Gas E&P
A$1.03B$16.19-0.61%$132.56M17.99x0.86
United States
54
MNTN
MNTN INC
NYSE
Software - Application
A$749.07M$10.147.53%-$9.62M-78.00x0.24
United States
34
BWMX
BETTERWARE DE MEXICO SAPI DE CV
NYSE
Specialty Retail
A$628.04M$16.83-1.06%$169.03MN/A5.58
Mexico
39
NATR
NATURES SUNSHINE PRODUCTS INC
NASDAQ
Packaged Foods
A$466.75M$26.66-1.84%$47.78M24.69x0.62
United States
35
ASMB
ASSEMBLY BIOSCIENCES INC
NASDAQ
Biotechnology
A$434.16M$27.371.56%-$5.99M-49.76x0.25
United States
26
PKOH
PARK OHIO HOLDINGS CORP
NASDAQ
Specialty Industrial Machinery
A$410.95M$28.54-1.42%$107.10M16.50x2.72
United States
45
ELMD
ELECTROMED INC
NYSEMKT
Medical Devices
A$211.85M$25.60-0.43%$13.13M23.93x0.21
United States
45
INFU
INFUSYSTEM HOLDINGS INC
NYSEMKT
Medical Instruments & Supplies
A$209.63M$10.372.37%$25.22M32.41x0.75
United States
38
PMTS
CPI CARD GROUP INC
NASDAQ
Credit Services
A$199.18M$17.38-1.86%$76.53M13.17x-24.26
United States
32

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have access to Premium? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.